Literature DB >> 12517686

Hemodynamic effects of nicotinic acid infusion in normotensive and hypertensive subjects.

Crystal A Gadegbeku1, Arachelvi Dhandayuthapani, M Zakaria Shrayyef, Brent M Egan.   

Abstract

Nicotonic acid (NA) infusions are associated with peripheral vasodilation from the generation of vascular prostaglandins with minimal effects on blood pressure (BP) in normotensive subjects. We studied the effects of a NA infusion in 10 hypertensive and 11 normotensive individuals to further characterize systemic hemodynamic responses to NA using pulse waveform analysis. Blood pressure, stroke volume, cardiac output, total peripheral resistance, large and small artery elasticity were determined before and after a 1-h NA infusion. In the normotensives, systolic, diastolic, mean BP, and pulse pressure were not affected by NA. In contrast, the hypertensive subjects experienced a decrease in mean BP from 105 +/- 2 mm Hg to 100 +/- 3 mm Hg (P <.01) accompanied by significant decreases in systolic, diastolic, and pulse pressures. The differential BP response occurred despite comparable increases in heart rate (11% to 13%, P </=.05) and similar decreases in total peripheral resistance (6%, P </=.05) in both groups. However, the normotensive group demonstrated a decrease in overall vascular compliance, measured as stroke volume to pulse pressure ratio, from 2.12 +/- 0.09 to 1.93 +/- 0.09 mL/mm Hg (P <.05). This finding was supported by a decrease in C1 (large artery compliance), assessed by pulse waveform analysis, from 15.8 +/- 1 to 14.2 +/- 1 mL/mm Hg (P <.05). In contrast, overall compliance and C1 were unchanged after the NA infusion in the hypertensive group. These results suggest that there is a differential hemodynamic response to NA infusion in normotensive and hypertensive individuals. The adjustment in vascular compliance may be an important factor in determining overall BP response to NA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517686     DOI: 10.1016/s0895-7061(02)03196-5

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  8 in total

1.  Effect of niacin on the choroidal circulation of patients with age related macular degeneration.

Authors:  T I Metelitsina; J E Grunwald; J C DuPont; G-S Ying
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

2.  Prolonged niacin treatment leads to increased adipose tissue PUFA synthesis and anti-inflammatory lipid and oxylipin plasma profile.

Authors:  Mattijs M Heemskerk; Harish K Dharuri; Sjoerd A A van den Berg; Hulda S Jónasdóttir; Dick-Paul Kloos; Martin Giera; Ko Willems van Dijk; Vanessa van Harmelen
Journal:  J Lipid Res       Date:  2014-10-15       Impact factor: 5.922

Review 3.  Does nicotinic acid (niacin) lower blood pressure?

Authors:  H E Bays; D J Rader
Journal:  Int J Clin Pract       Date:  2008-11-28       Impact factor: 2.503

4.  Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study.

Authors:  Anastazia Kei; Moses Elisaf; Elisavet Moutzouri; Stavroula Tsiara; Evangelos Liberopoulos
Journal:  Int J Hypertens       Date:  2011-05-15       Impact factor: 2.420

5.  Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters.

Authors:  Helen Vosper
Journal:  Clin Med Insights Cardiol       Date:  2011-09-19

Review 6.  The treatment of migraines and tension-type headaches with intravenous and oral niacin (nicotinic acid): systematic review of the literature.

Authors:  Jonathan Prousky; Dugald Seely
Journal:  Nutr J       Date:  2005-01-26       Impact factor: 3.271

7.  Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.

Authors:  Roni Nielsen; Niels Møller; Lars C Gormsen; Lars Poulsen Tolbod; Nils Henrik Hansson; Jens Sorensen; Hendrik Johannes Harms; Jørgen Frøkiær; Hans Eiskjaer; Nichlas Riise Jespersen; Søren Mellemkjaer; Thomas Ravn Lassen; Kasper Pryds; Hans Erik Bøtker; Henrik Wiggers
Journal:  Circulation       Date:  2019-04-30       Impact factor: 29.690

8.  Intravenous niacin acutely improves the efficiency of dietary fat storage in lean and obese humans.

Authors:  Robert H Nelson; Danielle Vlazny; Almira Smailovic; John M Miles
Journal:  Diabetes       Date:  2012-08-24       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.